[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Lyra Therapeutics Inc (LYRA)

Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 355
  • Shares Outstanding, K 1,775
  • Annual Sales, $ 400 K
  • Annual Income, $ -28,920 K
  • EBIT $ -31 M
  • EBITDA $ -31 M
  • 60-Month Beta 0.59
  • Price/Sales 0.04
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -18.65
  • Most Recent Earnings $-3.76 on 03/31/26
  • Next Earnings Date 09/01/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0004 +49,900.00%
on 08/20/26
0.4500 -55.56%
on 08/05/26
-0.2750 (-57.89%)
since 07/29/26
3-Month
0.0004 +49,900.00%
on 08/20/26
0.8000 -75.00%
on 06/09/26
-0.5000 (-71.43%)
since 06/02/26
52-Week
0.0004 +49,900.00%
on 08/20/26
8.7478 -97.71%
on 10/06/25
-7.2100 (-97.30%)
since 09/02/25

Most Recent Stories

More News
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC

WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities...

LYRA : 0.2000 (unch)
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC

WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the

LYRA : 0.2000 (unch)
Lyra Therapeutics Provides Corporate Update

WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”) today announced that its Board of Directors has decided to suspend further...

LYRA : 0.2000 (unch)
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

–  Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission – WATERTOWN, Mass., Nov. 12,...

LYRA : 0.2000 (unch)
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

LYRA : 0.2000 (unch)
William Blair Keeps Their Hold Rating on Lyra Therapeutics (LYRA)

In a report released today, Lachlan Hanbury Brown from William Blair maintained a Hold rating on Lyra Therapeutics. The company’s shares closed yesterday at $7.92.Elevate Your Investing Strategy: Take...

LYRA : 0.2000 (unch)
William Blair Reaffirms Their Hold Rating on Lyra Therapeutics (LYRA)

William Blair analyst Lachlan Hanbury Brown maintained a Hold rating on Lyra Therapeutics today. The company’s shares opened today at $7.47.Elevate Your Investing Strategy: Take advantage of TipRanks...

LYRA : 0.2000 (unch)
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study

Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission  Positive ENLIGHTEN 2 results highlighted at the AAO-HNS...

LYRA : 0.2000 (unch)
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study

Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission  Positive ENLIGHTEN 2 results highlighted at the AAO-HNS 2025 Annual Meeting WATERTOWN, Mass., Oct....

LYRA : 0.2000 (unch)
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

– Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LYR-210...

LYRA : 0.2000 (unch)

Business Summary

Lyra Therapeutics Inc. is a clinical-stage therapeutics company. It is focused on the development and commercialization of novel integrated drug and delivery solutions for patients with ear, nose and throat diseases. The company's proprietary technology platform, XTreo(TM), is designed to precisely and...

See More

Key Turning Points

3rd Resistance Point 0.4617
2nd Resistance Point 0.3333
1st Resistance Point 0.2667
Last Price 0.2000
1st Support Level 0.0717
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 8.7478
Fibonacci 61.8% 5.4063
Fibonacci 50% 4.3741
Fibonacci 38.2% 3.3419
Last Price 0.2000
52-Week Low 0.0004

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.